Bioscience

HTG announces the addition of Dr. Lee Hartwell to Scientific Advisory Board

April 28, 2010

By Flinn Foundation

[Source: Earth Times] – HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced that Lee Hartwell, Ph.D., President & Director, Fred Hutchinson Cancer Research Center, 2001 Nobel Laureate, and Timothy Yeatman, M.D., Executive Vice President, Co-Founder & C.S.O. of M2Gen, have agreed to join HTG’s Scientific Advisory Board (SAB).

For more information: HTG Announces the Addition of Dr. Lee Hartwell and Dr. Timothy Yeatman to Scientific Advisory Board